Moleculin Biotech Inc (NASDAQ: MBRX) established initial surge of 3.03% at $0.51, as the Stock market unbolted on Wednesday, before settling in for the price of $0.5 at the close. Taking a more long-term approach, MBRX posted a 52-week range of $0.25-$3.65.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 26.36%. Meanwhile, its Annual Earning per share during the time was 26.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 80.33%. This publicly-traded company’s shares outstanding now amounts to $49.50 million, simultaneously with a float of $45.11 million. The organization now has a market capitalization sitting at $25.24 million.
Moleculin Biotech Inc (MBRX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Moleculin Biotech Inc industry. Moleculin Biotech Inc’s current insider ownership accounts for 8.87%, in contrast to 0.87% institutional ownership. According to the most recent insider trade that took place on Jun 23 ’25, this organization’s Chief Financial Officer bought 270,270 shares at the rate of 0.37, making the entire transaction reach 100,000 in total value, affecting insider ownership by 287,587. Preceding that transaction, on Jun 23 ’25, Company’s CEO and President bought 675,675 for 0.37, making the whole transaction’s value amount to 250,000. This particular insider is now the holder of 743,607 in total.
Moleculin Biotech Inc (MBRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
Moleculin Biotech Inc’s EPS increase for this current 12-month fiscal period is 80.33% and is forecasted to reach -1.05 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.64% through the next 5 years, which can be compared against the 26.36% growth it accomplished over the previous five years trading on the market.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
Let’s observe the current performance indicators for Moleculin Biotech Inc (MBRX). It’s Quick Ratio in the last reported quarter now stands at 1.15.
In the same vein, MBRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.59, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -1.05 at the market close of one year from today.
